Neuromyelitis Optica Latest Advances

Find the Latest Research About Neuromyelitis Optica

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6609 publications

Dermatomal pruritus as a heralding symptom in AQP4-positive LETM with anti-Ro52 positivity.

Dermatomal pruritus as a heralding symptom in AQP4-positive LETM with anti-Ro52 positivity.

Journal: BMJ case reports
Published: January 16, 2026

Prognostic Modeling for the Failure of Intravenous Methylprednisolone and the Risk of Visual Disability in AQP4-IgG Positive NMOSD-ON.

Prognostic Modeling for the Failure of Intravenous Methylprednisolone and the Risk of Visual Disability in AQP4-IgG Positive NMOSD-ON.

Journal: Translational vision science & technology
Published: January 14, 2026

Pain in NMOSD is not always neuropathic: multifocal avascular osteonecrosis mimicking neuropathic pain.

Pain in NMOSD is not always neuropathic: multifocal avascular osteonecrosis mimicking neuropathic pain.

Journal: BMJ case reports
Published: January 13, 2026

Immunotherapies for neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.

Immunotherapies for neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.

Journal: Handbook of clinical neurology
Published: January 12, 2026

Outcomes of Children With Optic Neuritis as Their First Demyelinating Event.

Outcomes of Children With Optic Neuritis as Their First Demyelinating Event.

Journal: Journal of child neurology
Published: January 09, 2026

Chinese neuroimmunological disease (NIDBase) cohort study: cohort profile.

Chinese neuroimmunological disease (NIDBase) cohort study: cohort profile.

Journal: BMJ open
Published: January 08, 2026

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 07, 2026

Astrocyte-derived extracellular vesicles as antigen-specific therapy for neuromyelitis optica spectrum disorder in the mouse model.

Astrocyte-derived extracellular vesicles as antigen-specific therapy for neuromyelitis optica spectrum disorder in the mouse model.

Journal: bioRxiv : the preprint server for biology
Published: January 07, 2026

Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments.

Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 06, 2026

Optimizing kappa free light chain index thresholds for multiple sclerosis (MS) diagnosis in low-MS prevalence regions: Insights from an Asian cohort.

Optimizing kappa free light chain index thresholds for multiple sclerosis (MS) diagnosis in low-MS prevalence regions: Insights from an Asian cohort.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 27, 2025

Progression Independent of Relapse Activity in Aquaporin-4-IgG-Positive NMOSD: A Decade-Long Cohort Study.

Progression Independent of Relapse Activity in Aquaporin-4-IgG-Positive NMOSD: A Decade-Long Cohort Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: December 23, 2025

Complement C4d Informs the Differential Diagnosis of Inflammatory Demyelinating CNS Diseases.

Complement C4d Informs the Differential Diagnosis of Inflammatory Demyelinating CNS Diseases.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: December 23, 2025
Showing 1-12 of 6,609

Last Updated: 02/24/2026